Arch Therapeutics
Pre-clinicalDevelops self-assembling peptide technology for controlling bleeding and fluid leakage during surgery and wound care.
Founded
2006
Focus
Medical DevicesHemostasis
About
Develops self-assembling peptide technology for controlling bleeding and fluid leakage during surgery and wound care.
Funding History
4Total raised: $12M
Series C$2MUndisclosedSep 15, 2018
Debt$1.5MUndisclosedMar 15, 2017
Series B$3.5MUndisclosedJun 15, 2015
Series A$5MUndisclosedJan 15, 2014
Company Info
TypePrivate
Founded2006
LocationFramingham, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile